542650 Stock Overview Provides diagnostic services in India and internationally. More details
Rewards Risk Analysis No risks detected for 542650 from our risk checks.
See All Risk Checks Capture your thoughts, links and company narrative
Metropolis Healthcare Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Metropolis Healthcare Historical stock prices Current Share Price ₹2,050.15 52 Week High ₹2,306.85 52 Week Low ₹1,450.05 Beta 0.34 1 Month Change -1.25% 3 Month Change -8.25% 1 Year Change 20.80% 3 Year Change -38.51% 5 Year Change 29.69% Change since IPO 113.66%
Recent News & Updates Metropolis Healthcare Limited (NSEI:METROPOLIS) agreed to acquire Core Diagnostics Private Limited from Core Diagnostics (Mauritius) Private Limited for INR 2.46 billion. Dec 10
Metropolis Healthcare Limited Announces Management Changes Nov 28
Second quarter 2025 earnings: EPS misses analyst expectations Nov 09
Metropolis Healthcare Limited Appoints Aditya Shinde as Interim Chief Financial Officer, Effective November 11, 2024 Nov 08
Metropolis Healthcare Limited to Report Q2, 2025 Results on Nov 08, 2024 Oct 31 Metropolis Healthcare Limited Announces Resignation of Rakesh Agarwal as Chief Financial Officer, Effective November 10, 2024 Oct 12
See more updates Metropolis Healthcare Limited (NSEI:METROPOLIS) agreed to acquire Core Diagnostics Private Limited from Core Diagnostics (Mauritius) Private Limited for INR 2.46 billion. Dec 10
Metropolis Healthcare Limited Announces Management Changes Nov 28
Second quarter 2025 earnings: EPS misses analyst expectations Nov 09
Metropolis Healthcare Limited Appoints Aditya Shinde as Interim Chief Financial Officer, Effective November 11, 2024 Nov 08
Metropolis Healthcare Limited to Report Q2, 2025 Results on Nov 08, 2024 Oct 31 Metropolis Healthcare Limited Announces Resignation of Rakesh Agarwal as Chief Financial Officer, Effective November 10, 2024 Oct 12
Metropolis Healthcare Limited Appoints Pinakin Shah as Chief Information Officer Sep 07 Metropolis Healthcare Limited Announces Changes in Board
Founder & Chairman Emeritus recently sold ₹136m worth of stock Aug 22
Metropolis Healthcare Limited to Report Q1, 2025 Results on Aug 10, 2024 Aug 05
Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Aug 02 Metropolis Healthcare Limited, Annual General Meeting, Aug 21, 2024
Metropolis Healthcare Limited, Annual General Meeting, Aug 21, 2024 Jul 29
Founder & Chairman Emeritus recently sold ₹51m worth of stock Jun 13
Price target increased by 7.4% to ₹1,861 Jun 08
Metropolis Healthcare Limited Appoints Sushil Shah as Chairman Emeritus, Effective May 22, 2024 May 23
Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind May 22
Metropolis Healthcare Limited to Report Q4, 2024 Results on May 21, 2024 May 16
Founder & Executive Chairman recently sold ₹62m worth of stock Apr 03
Third quarter 2024 earnings: EPS misses analyst expectations Feb 05
Metropolis Healthcare Limited Announces Management Changes Feb 02
Metropolis Healthcare Limited to Report Q3, 2024 Results on Feb 02, 2024 Jan 27
Upcoming dividend of ₹4.00 per share at 0.5% yield Nov 10
Price target increased by 7.4% to ₹1,528 Nov 07
Second quarter 2024 earnings: EPS misses analyst expectations Nov 07
Metropolis Healthcare Limited to Report Q2, 2024 Results on Nov 04, 2023 Oct 29
Metropolis Healthcare Limited Announces the Cessation of Milind Sarwate as an Independent Director, Chairman/Member of Audit Committee, Risk Management Committee and Corporate Social Responsibility Committee, Effective September 06, 2023 Sep 07
Metropolis Healthcare Limited to Report Q1, 2024 Results on Aug 02, 2023 Jul 28
Full year 2023 earnings: EPS and revenues miss analyst expectations Jul 26
Metropolis Healthcare Limited, Annual General Meeting, Aug 17, 2023 Jul 24
Metropolis Healthcare Limited Appoints Neha Shah as Interim Company Secretary Jun 22
Insufficient new directors Jun 01
Price target decreased by 7.5% to ₹1,397 May 19
Full year 2023 earnings: EPS and revenues miss analyst expectations May 17
Metropolis Healthcare Limited to Report Q4, 2023 Results on May 16, 2023 May 11
Upcoming dividend of ₹8.00 per share at 0.6% yield Feb 16
Third quarter 2023 earnings: EPS and revenues miss analyst expectations Feb 12
Metropolis Healthcare Limited Declares Interim Dividend for the Financial Year 2022-23 Feb 11
Metropolis Healthcare Limited to Report Q3, 2023 Results on Feb 10, 2023 Feb 04
Second quarter 2023 earnings: EPS misses analyst expectations Nov 10
Metropolis Healthcare Limited to Report Q2, 2023 Results on Nov 08, 2022 Nov 02
Metropolis Healthcare Limited Announces Resignation of Vijender Singh as Chief Execution Officer Aug 19
Metropolis Healthcare Limited Proposes to Confirm the Payment of Interim Dividend for the Financial Year Ended March 31, 2022 Aug 18
Price target decreased to ₹1,746 Aug 14
Metropolis Healthcare Limited to Report Q1, 2023 Results on Aug 10, 2022 Aug 04
Metropolis Healthcare Limited Announces Resignation of Chief Executive Officer, Effective November 30, 2022 Jul 30
Full year 2022 earnings: EPS and revenues miss analyst expectations Jul 28
Metropolis Healthcare Limited, Annual General Meeting, Aug 17, 2022 Jul 22
Metropolis Healthcare Limited to Report Q4, 2022 Final Results on Jul 18, 2022 Jul 13
GSK Velu Reportedly in Talks with Investors, PEs & Banking Firms to Buy Back Metropolis Healthcare Jun 15 Metropolis Confirms Promoters Have No Intention to Exit the Business
Adani, Apollo Reportedly Explore Bids for Majority Stake in Metropolis Jun 07
Price target decreased to ₹2,461 May 26
Full year 2022 earnings: EPS and revenues miss analyst expectations May 26
Amazon, Flipkart Reportedly in Talks to Buy Stake in Metropolis Healthcare May 21
Metropolis Healthcare Limited to Report Q4, 2022 Results on May 24, 2022 May 17
Investor sentiment improved over the past week Apr 05
Founder & Executive Chairman recently bought ₹100m worth of stock Feb 23
Investor sentiment deteriorated over the past week Feb 18
Upcoming dividend of ₹8.00 per share Feb 14
Third quarter 2022 earnings: EPS and revenues miss analyst expectations Feb 13
Metropolis Healthcare Limited Declares Payment of an Interim Dividend Feb 12
Metropolis Healthcare Limited to Report Q3, 2022 Results on Feb 11, 2022 Feb 04
Investor sentiment deteriorated over the past week Jan 24
Insider recently sold ₹820k worth of stock Jan 01
Price target increased to ₹2,998 Dec 01
Founder & Executive Chairman recently sold ₹1.3b worth of stock Nov 18
Second quarter 2022 earnings released: EPS ₹11.39 (vs ₹11.88 in 2Q 2021) Nov 11
High number of new directors Oct 31
Key Executive recently sold ₹4.8m worth of stock Sep 14
Insider recently sold ₹1.7m worth of stock Sep 04
Price target increased to ₹2,789 Aug 09
Full year 2021 earnings released: EPS ₹35.97 (vs ₹25.36 in FY 2020) Jul 20
Suburban Diagnostics Reportedly in Sale Talks with Dr. Lal PathLabs, Metropolis, Pharmeasy, Others Jun 18
Company Secretary & Compliance Officer Poonam Tanwani has left the company Jun 04
Insider recently sold ₹7.8m worth of stock Jun 03
Price target increased to ₹2,466 May 31
Full year 2021 earnings released: EPS ₹35.97 (vs ₹25.36 in FY 2020) May 30
Chief Executive Officer recently sold ₹5.2m worth of stock Mar 31
Insider recently sold ₹999k worth of stock Mar 23
Chief Executive Officer recently sold ₹109m worth of stock Feb 24
Third quarter 2021 earnings released: EPS ₹11.50 (vs ₹8.38 in 3Q 2020) Feb 12
Revenue and earnings miss expectations Feb 12
Metropolis Healthcare Limited Revises Constitution of the Nomination and Remuneration Committee, with Effect from February 10, 2021 Feb 11
Metropolis Healthcare Limited to Report Q3, 2021 Results on Feb 10, 2021 Feb 05
Price target raised to ₹2,193 Jan 19
Metropolis Healthcare Limited (NSEI:METROPOLIS) agreed to acquire Dr. Ganesan's Hitech Diagnostic Centre Private Limited from Ganesan Subramanian, Manimegalai Ganesan and Malini Parasuraman for INR 6.2 billion. Jan 19
Insider recently sold ₹2.7m worth of stock Jan 08
Insider recently sold ₹2.0m worth of stock Dec 12
Insider recently sold ₹2.0m worth of stock Nov 21
New 90-day high: ₹2,040 Nov 18
Price target raised to ₹2,034 Nov 14
Second quarter 2021 earnings released: EPS ₹11.88 Nov 14
Revenue and earnings beat expectations Nov 14
Metropolis Healthcare Limited (NSEI:METROPOLIS) completed the acquisition of remaining 49% stake in Raj Metropolis Healthcare Private Limited. Nov 06 Shareholder Returns 542650 IN Healthcare IN Market 7D 1.1% 2.0% 1.8% 1Y 20.8% 37.3% 18.0%
See full shareholder returns
Return vs Market: 542650 exceeded the Indian Market which returned 17.4% over the past year.
Price Volatility Is 542650's price volatile compared to industry and market? 542650 volatility 542650 Average Weekly Movement 3.7% Healthcare Industry Average Movement 5.2% Market Average Movement 6.2% 10% most volatile stocks in IN Market 9.0% 10% least volatile stocks in IN Market 4.1%
Stable Share Price: 542650 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 542650's weekly volatility (4%) has been stable over the past year.
About the Company Metropolis Healthcare Limited provides diagnostic services in India and internationally. The company offers clinical laboratory testing, and profiles services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates.
Show more Metropolis Healthcare Limited Fundamentals Summary How do Metropolis Healthcare's earnings and revenue compare to its market cap? 542650 fundamental statistics Market cap ₹105.05b Earnings (TTM ) ₹1.48b Revenue (TTM ) ₹12.85b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 542650 income statement (TTM ) Revenue ₹12.85b Cost of Revenue ₹2.84b Gross Profit ₹10.01b Other Expenses ₹8.53b Earnings ₹1.48b
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) 28.87 Gross Margin 77.88% Net Profit Margin 11.52% Debt/Equity Ratio 0%
How did 542650 perform over the long term?
See historical performance and comparison Dividends
0.2% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/02 05:18 End of Day Share Price 2025/01/02 00:00 Earnings 2024/09/30 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Metropolis Healthcare Limited is covered by 33 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Prashant Nair Ambit Capital null null Antique Stockbroking Ltd. Harith Ahamed Avendus Spark
Show 30 more analysts 
